Brinker Capital Investments’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,661
| Closed | -$245K | – | 1882 |
|
|
2024
Q3 | $245K | Buy |
3,661
+1,443
| +65% | +$96.4K | ﹤0.01% | 1623 |
|
|
2024
Q2 | $263K | Buy |
+2,218
| New | +$263K | ﹤0.01% | 1509 |
|
|
2024
Q1 | – | Sell |
-2,538
| Closed | -$293K | – | 1726 |
|
|
2023
Q4 | $293K | Sell |
2,538
-1,939
| -43% | -$224K | ﹤0.01% | 1411 |
|
|
2023
Q3 | $462K | Sell |
4,477
-6,392
| -59% | -$660K | 0.01% | 1230 |
|
|
2023
Q2 | $1.32M | Buy |
10,869
+583
| +6% | +$70.8K | 0.01% | 830 |
|
|
2023
Q1 | $1.58M | Buy |
10,286
+1,757
| +21% | +$270K | 0.02% | 691 |
|
|
2022
Q4 | $1.53M | Buy |
8,529
+1,956
| +30% | +$351K | 0.03% | 580 |
|
|
2022
Q3 | $777K | Buy |
6,573
+3,666
| +126% | +$433K | 0.02% | 800 |
|
|
2022
Q2 | $415K | Buy |
2,907
+1,238
| +74% | +$177K | 0.01% | 1044 |
|
|
2022
Q1 | $288K | Buy |
1,669
+489
| +41% | +$84.4K | ﹤0.01% | 1237 |
|
|
2021
Q4 | $300K | Buy |
+1,180
| New | +$300K | ﹤0.01% | 1257 |
|